2 weeks Ago By ABMN Staff
Tempus AI, Inc. ( NASDAQ:TEM – Get Free Report ) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 2,970,000 shares, a decline of 16.
3% from the August 31st total of 3,550,000 shares. Based on an average daily trading volume, of 1,100,000 shares, the days-to-cover ratio is presently 2.7 days.
Currently, 5.8% of the shares of the company are short sold. Analysts Set New Price Targets TEM has been the topic of several recent research reports.
Piper Sandler initiated coverage on shares of Tempus AI in a research report on Monday, August 12th. They issued a “neutral” rating and a $40.00 price target on the stock.
William Blair started coverage on Tempus AI in a report on Tuesday, July 9th. They issued an “outperform” rating on the stock. Bank of America started coverage on Tempus AI in a research report on Tuesday, July 9th.
They set a “buy” rating and a $41.00 target price on the stock. Loop Capital assumed coverage on Tempus AI in a research report on Tuesday, July 9th.
They issued a “buy” rating and a $48.00 price target for the company. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $47.
00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. One analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.
com, the stock has an average rating of “Moderate Buy” and an average price target of $45.56. Check Out Our Latest Analysis on TEM Tempus AI Trading Up 3.
8 % Tempus AI ( NASDAQ:TEM – Get Free Report ) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.
41) by ($2.36). The business had revenue of $165.
97 million during the quarter, compared to analyst estimates of $159.10 million. On average, equities research analysts anticipate that Tempus AI will post -6.
51 EPS for the current fiscal year. Institutional Trading of Tempus AI Hedge funds have recently bought and sold shares of the stock. Sandia Investment Management LP purchased a new stake in shares of Tempus AI in the second quarter worth about $136,000.
Northwestern University purchased a new position in shares of Tempus AI in the second quarter valued at $491,000. Squarepoint Ops LLC bought a new stake in Tempus AI in the second quarter worth $633,000. WINTON GROUP Ltd purchased a new stake in Tempus AI during the second quarter valued at $634,000.
Finally, Scientech Research LLC purchased a new position in shares of Tempus AI in the 2nd quarter worth $756,000. Tempus AI Company Profile ( Get Free Report ) Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter ..
